Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 2/2002

01-03-2002

Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcinoma in vitro

Authors: Claudia Rudroff, Stefan Seibold, Roland Kaufmann, Cecilia Cu Zetina, Kathrin Reise, Ute Schäfer, Annette Schneider, Michael Brockmann, Johannes Scheele, Edmund A.M. Neugebauer

Published in: Clinical & Experimental Metastasis | Issue 2/2002

Login to get access
Metadata
Title
Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcinoma in vitro
Authors
Claudia Rudroff
Stefan Seibold
Roland Kaufmann
Cecilia Cu Zetina
Kathrin Reise
Ute Schäfer
Annette Schneider
Michael Brockmann
Johannes Scheele
Edmund A.M. Neugebauer
Publication date
01-03-2002
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 2/2002
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1014598904644

Other articles of this Issue 2/2002

Clinical & Experimental Metastasis 2/2002 Go to the issue

OriginalPaper

Resistance to apoptosis is increased during metastatic dissemination of colon cancer

OriginalPaper

Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells

OriginalPaper

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

OriginalPaper

Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells

OriginalPaper

Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth

OriginalPaper

Regulation of melanoma cell migration and invasion by laminin-5 and α3β1 integrin (VLA-3)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits